^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    StemPrintER™

    Company:
    AccuStem
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    StemPrintER is a multi-gene signature assay intended for use as a prognostic tool in patients with estrogen-receptor positive ER+/HER2 negative breast cancers. This test to be used in conjunction with clinical evaluation to identify those patients at increased risk for early and/or late metastasis.
    Cancer:
    Estrogen Receptor Positive Breast Cancer, HER2 Negative Breast Cancer
    Gene:
    ER (Estrogen receptor), HER-2 (Human epidermal growth factor receptor 2)
    Method:
    RT-PCR